Sign In
Buy BCAX
Bicara Therapeutics . Common Stock Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -57.04. In total, the insiders bought 896.14K and sold 229.99K BCAX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-57.04 |
| ● Buy | 896.14K shares |
| ● Sell | 229.99K shares |
|
67% Buy Activity
Moderate Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 09, 2026 Buy |
Haviland Kate Director |
19 475 Value: $400.4K |
||
|
Jun 09, 2026 Buy |
Simson Jake Director |
19 475 Value: $400.4K |
||
|
May 21, 2026 Buy |
Hyep Ivan Chief Financial Officer |
9 200 Value: $34.9K |
||
|
May 21, 2026 Sell |
Hyep Ivan Chief Financial Officer |
9 200 Value: $187.9K |
||
|
May 21, 2026 Buy |
Hyep Ivan Chief Financial Officer |
9 200 Value: $34.9K |
||
|
May 18, 2026 Buy |
Mazumdar Claire Chief Executive Officer |
15 000 Value: $56.8K |
||
|
May 18, 2026 Sell |
Mazumdar Claire Chief Executive Officer |
12 022 Value: $240.0K |
||
|
May 18, 2026 Sell |
Mazumdar Claire Chief Executive Officer |
2 978 Value: $60.6K |
||
|
May 18, 2026 Buy |
Mazumdar Claire Chief Executive Officer |
15 000 Value: $56.8K |
||
|
May 15, 2026 Buy |
Cohlhepp Ryan President And COO |
8 000 Value: $30.3K |
||
|
May 15, 2026 Sell |
Cohlhepp Ryan President And COO |
4 500 Value: $91.3K |
||
|
May 15, 2026 Sell |
Cohlhepp Ryan President And COO |
8 000 Value: $162.3K |
||
|
May 15, 2026 Buy |
Cohlhepp Ryan President And COO |
8 000 Value: $30.3K |
||
|
May 08, 2026 Buy |
Schelman William Chief Medical Officer |
25 000 Value: $419.0K |
||
|
May 08, 2026 Buy |
Schelman William Chief Medical Officer |
150 000 Value: $2.49M |
||
|
May 08, 2026 Buy |
Schelman William Chief Medical Officer |
85 000 Value: $1.92M |
||
|
Apr 27, 2026 Buy |
Raben David Chief Medical Officer |
5 500 Value: $20.8K |
||
|
Apr 27, 2026 Buy |
Raben David Chief Medical Officer |
5 500 Value: $20.8K |
||
|
Apr 27, 2026 Sell |
Raben David Chief Medical Officer |
5 500 Value: $125.8K |
||
|
Apr 21, 2026 Buy |
Hyep Ivan Chief Financial Officer |
9 200 Value: $34.9K |
||
|
Apr 21, 2026 Sell |
Hyep Ivan Chief Financial Officer |
9 200 Value: $211.6K |
||
|
Apr 21, 2026 Buy |
Hyep Ivan Chief Financial Officer |
9 200 Value: $34.9K |
||
|
Apr 20, 2026 Buy |
Mazumdar Claire Chief Executive Officer |
15 000 Value: $56.8K |
||
|
Apr 20, 2026 Sell |
Mazumdar Claire Chief Executive Officer |
15 000 Value: $354.1K |
||
|
Apr 20, 2026 Buy |
Mazumdar Claire Chief Executive Officer |
15 000 Value: $56.8K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
